Catalyst Wire Dossier Catalyst Wire Dossier

Rabreprazole

rabreprazole · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rabreprazole, covering 2011-01-10 to 2011-01-10. Get the full timeline:

Most recent: Clinical Trial Update: A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive [Phase 1]

See pricing